Walgreens earnings slide as number of vaccinations wane

A big opioid settlement and a COVID-19 vaccine slowdown dragged on third-quarter earnings for Walgreens, but the drugstore chain still topped expectations.

Net income slid to $289 million in the quarter that ended May 31, the company said Thursday. That’s down from about $1.2 billion the previous year.

Walgreens booked a $683 million charge from a settlement announced last month with the state of Florida to resolve claims tied to dispensing…